Literature DB >> 14768061

Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.

Heike Weighardt1, Gabriela Jusek, Jörg Mages, Roland Lang, Kasper Hoebe, Bruce Beutler, Bernhard Holzmann.   

Abstract

Dendritic cell activation by Toll-like receptors (TLR) is crucial for the generation of protective immune responses. In addition to the common myeloid differentiation factor 88 (MyD88)-dependent signaling pathway, TLR4 engages the adaptor protein Toll/IL-1 receptor (TIR)-domain-containing adaptor inducing IFN-beta (TRIF), leading to interferon regulatory factor 3 (IRF-3) activation and type I interferon production. Using microarray expression profiling we now identify TRIF as a major regulator of the TLR4-triggered activation program of dendritic cells. We show that the expression of 47% of the genes that are responsive to TLR4 stimulation in wild-type dendritic cells is significantly altered in cells carrying a loss-of-function mutation of TRIF. Specifically, expression of IL-12, IL-18, and IL-23 was impaired in the absence of functional TRIF, suggesting that TLR4-promoted Th1 responses are TRIF-dependent. Furthermore, we provide evidence that TRIF regulates TLR4-mediated gene expression both by type I IFN-dependent and -independent mechanisms. Whereas dendritic cell production of CXCL10 and CCL12 was dependent on both TRIF and the type I interferon receptor, expression of IL-6 required TRIF but not type I interferon activity. Functional TRIF was also required for the normal induction of numerous genes considered important for host defense against diverse pathogens.Together, these data therefore identify TRIF as a crucial regulator of TLR4-dependent dendritic cell responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14768061     DOI: 10.1002/eji.200324714

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  50 in total

Review 1.  Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance.

Authors:  Wei Jin; Mikyoung Chang; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

2.  Exacerbation of allergen-induced eczema in TLR4- and TRIF-deficient mice.

Authors:  Eric B Brandt; Aaron M Gibson; Stacey Bass; Carolyn Rydyznski; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

3.  Central role of toll-like receptor 4 signaling and host defense in experimental pneumonia caused by Gram-negative bacteria.

Authors:  Jill R Schurr; Erana Young; Pat Byrne; Chad Steele; Judd E Shellito; Jay K Kolls
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Novel pharmacologic treatment attenuates septic shock and improves long-term survival.

Authors:  Ting Zhao; Yongqing Li; Baoling Liu; Zhengcai Liu; Wei Chong; Xiuzhen Duan; Danielle K Deperalta; George C Velmahos; Hasan B Alam
Journal:  Surgery       Date:  2013-08       Impact factor: 3.982

5.  Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2.

Authors:  Seung Hyun Han; Je Hak Kim; Ho Seong Seo; Michael H Martin; Gook-Hyun Chung; Suzanne M Michalek; Moon H Nahm
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 6.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

7.  Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells.

Authors:  Flávio V Loures; Adriana Pina; Maíra Felonato; Eliseu F Araújo; Katia R M Leite; Vera L G Calich
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

Review 8.  Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant.

Authors:  C R Casella; T C Mitchell
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

9.  The toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery.

Authors:  Anke Leichtle; Michelle Hernandez; Kwang Pak; Nicholas J Webster; Stephen I Wasserman; Allen F Ryan
Journal:  BMC Immunol       Date:  2009-08-05       Impact factor: 3.615

10.  Using distinct molecular signatures of human monocytes and dendritic cells to predict adjuvant activity and pyrogenicity of TLR agonists.

Authors:  Richard Kenmoe Kamgang; Inês Ramos; Lurdes Rodrigues Duarte; Mascia Ghielmetti; Marina Freudenberg; Clemens Dahinden; Elisabetta Padovan
Journal:  Med Microbiol Immunol       Date:  2008-02-19       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.